PAI
ProQuest Associates IV Portfolio holdings
AUM
$53M
This Quarter Return
+4.08%
1 Year Return
+3.35%
3 Year Return
+116.54%
5 Year Return
–
10 Year Return
–
AUM
$65M
AUM Growth
+$65M
(-25%)
Cap. Flow
-$15.3M
Cap. Flow
% of AUM
-23.49%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
UroGen Pharma
URGN
|
$15.3M |
Sector Composition
| 1 | Healthcare | 87.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UroGen Pharma
URGN
$900M
| $39.3M | 60.44% |
789,297
-306,727
| -28% | -$15.3M |
|
2
Mersana Therapeutics
MRSN
$36.5M
| $17.1M | 26.27% |
955,709
| – | – |
|
|
IMDZ
3
DELISTED
Immune Design Corp.
IMDZ
| $5.63M | 8.66% |
1,236,394
| – | – |
|
|
AGRX
4
DELISTED
Agile Therapeutics, Inc
AGRX
| $2.5M | 3.85% |
5,062,363
| – | – |
|
|
EGRX
5
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $513K | 0.79% |
6,777
| – | – |
|